Skip to main content
China Resources Pharmaceutical Group Limited logo

China Resources Pharmaceutical Group Limited — Investor Relations & Filings

Ticker · 3320 ISIN · HK0000311099 LEI · 3003004H1KDKMJ8JD874 HKEX Manufacturing
Open in API
Filings indexed 813 across all filing types
Latest filing 2026-01-19 Report Publication Anno…
Country HK Hong Kong
Listing HKEX 3320

About China Resources Pharmaceutical Group Limited

http://www.crpharm.com

China Resources Pharmaceutical Group Limited operates an integrated pharmaceutical value chain encompassing research and development, manufacturing, distribution, and retail of medicines and healthcare products. As an investment holding company, it manages a diverse portfolio focused primarily on the domestic market. Its manufacturing capabilities span multiple therapeutic areas, including chemical drugs, biological drugs, natural medicine, and traditional Chinese medicine. The group leverages its extensive distribution network and retail operations to ensure broad market coverage across China.

Recent filings

Filing Released Lang Actions
Notification of publication of corporate communications on the Company's website
Report Publication Announcement Classification · 100% confidence The document is a notification sent to non-registered shareholders regarding the publication of corporate communications on the company's website. It provides instructions on how to access the circular and notice of the extraordinary general meeting online and includes a request form for shareholders to receive printed copies. Per the 'Menu vs Meal' rule, this is an announcement regarding the availability of documents rather than the documents themselves, making it a Report Publication Announcement (RPA).
2026-01-19 English
Letter to new shareholders - election of means of receipt of corporate communications
Legal Proceedings Report Classification · 95% confidence The document is a letter to shareholders regarding the election of means of receipt for corporate communications (electronic vs. printed). It includes an instruction slip for shareholders to return to the company's registrar. This is a standard administrative communication regarding shareholder services and does not constitute a financial report, proxy solicitation, or meeting notice itself, but rather a procedural notice. Under the provided definitions, this falls under the 'Regulatory Filings' category as a miscellaneous administrative filing.
2026-01-19 English
Letter to those shareholders who have elected to receive the corporate communications through the Company's website
Report Publication Announcement Classification · 100% confidence The document is a notification letter sent to shareholders informing them that a circular and proxy form for an upcoming extraordinary general meeting are available on the company's website. It includes an instruction slip for shareholders to request printed copies or change their communication preferences. According to the 'Menu vs Meal' rule, this is an announcement regarding the publication of documents rather than the documents themselves, making it a Report Publication Announcement (RPA).
2026-01-19 English
Letter to those shareholders who have elected to receive the printed form of corporate communications
Proxy Solicitation & Information Statement Classification · 98% confidence The document is a notification sent to shareholders regarding the availability of a circular and proxy form for an upcoming extraordinary general meeting. It includes an instruction slip for shareholders to elect their preferred method of receiving future corporate communications. This is a standard administrative communication regarding the distribution of meeting materials and does not constitute the meeting materials themselves, nor is it a report publication announcement for a financial report. Given the nature of the document as a shareholder notification regarding meeting logistics and communication preferences, it falls under the category of general regulatory filings.
2026-01-19 English
Proxy Form
Proxy Solicitation & Information Statement Classification · 100% confidence The document is explicitly titled 'Proxy form' for an 'extraordinary general meeting' (EGM). It provides instructions for shareholders to appoint a proxy to vote on specific resolutions (Sales Framework Agreement and New Articles of Association). This document is a standard proxy solicitation material sent to shareholders to facilitate voting at a meeting, which falls under the 'Proxy Solicitation & Information Statement' category.
2026-01-19 English
NOTICE OF THE 2026 FIRST EXTRAORDINARY GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal 'Notice of the 2026 First Extraordinary General Meeting' issued by China Resources Pharmaceutical Group Limited. It outlines the agenda, including ordinary and special resolutions, and provides instructions for shareholders regarding proxy voting, meeting attendance, and registration. This document is a solicitation of proxies and information for an upcoming shareholder meeting, which falls under the definition of Proxy Solicitation & Information Statement (PSI).
2026-01-19 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.